The Core Evidence Base: Visceral Fat Reduction Tesamorelin's best-established research finding, by a considerable margin, is its effect on visceral adipose tissue (VAT) the metabolically active fat surrounding internal organs, as distinct from subcutaneous fat
Wang, Y., Broderick, P., Matakidou, A., Eisen, T
Kassim M, Achoui M, Mansor M, et al
(Source) When this enzyme is present in great concentration within fat cells and is highly expressed, obesity is inevitable: In the study by Kannt and colleagues, NNMT expression is increased ~2-fold in subcutaneous and omental adipose tissue of type 2 diabetic subjects (men and women), compared to healthy controls Importantly, interventions that increase insulin sensitivity, such as exercise and bariatric surgery, also decreased expression of NNMT in adipose tissue For this reason alone, scientists have been interested in every possible method for inhibiting NNMT expression: We report that NNMT expression is increased in [white adipose tissue (WAT)] and liver of obese and diabetic mice
However, oral glutathione supplements introduce higher and more concentrated amounts into the system, and research on supplementation during breastfeeding remains limited
Thats really my driving force. 3
